Skip to main content
. 2017 Nov 15;8(66):109877–109888. doi: 10.18632/oncotarget.22436

Table 1. Univariate and Cox proportional hazards regression analysis of factors related to progression, cancer-specific mortality, and overall survival.

Progression Cancer-specific mortality Overall survival
Univariate Multivariate Univariate Multivariate Univariate Multivariate
Parameters HR (95%CI) P-value HR (95%CI) P-value HR (95%CI) P-value HR (95%CI) P-value HR (95%CI) P-value HR (95%CI) P-value
Gender
 Male 1 1 1
 Female 1.0 (0.8–1.2) 0.8177 1.0 (0.9–1.1) 1.0000 0.9 (0.8–1.1) 0.5608
Age
 <65 y.o 1 1 1
 ≥65 y.o 1.0 (0.8–1.2) 1.0000 1.0 (0.9–1.1) 1.0000 1.0 (0.9–1.2) 0.7755
Stage
 I 1 1 1 1 1 1
 ≥II 1.3 (1.0–1.8) 0.0164 3.0 (1.3–7.1) 0.0123 1.2 (1.0–1.4) 0.0267 1.8 (1.1–2.8) 0.0114 1.2 (1.0–1.4) 0.0428 3.0 (1.1–9.2) 0.0424
Fuhrman grade
 G1/2 1 1 1 1
 G3/4 1.4 (1.0–1.9) 0.0134 1.8 (0.8–4.3) 0.1481 1.1 (1.0–1.3) 0.0752 1.2 (0.9–1.4) 0.1134
LVI
 Yes 1 1 1
 No 1.7 (1.0–2.7) 0.0568 1.9 (1.1–3.2) 0.0856 1.4 (0.7–2.5) 0.3855
Exosomal-miR-224
 Low 1 1 1 1 1 1
 High 1.7 (1.4–2.2) <0.0001 11 (3.3–68.7) <0.0001 1.2 (1.1–1.4) 0.0027 1.6 (1.1–2.5) 0.0140 1.3 (1.1–1.5) 0.0009 9.1 (1.8–166.1) 0.0043

HR, hazard ratio; CI, confidence interval; LVI, lymphovascular invasion.